PR Newswire - Convergen Secures $10 Million Seed Funding to Adva...
SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, today an...
Read More

ภาษาไทย
English